4//SEC Filing
Taglietti Marco 4
Accession 0001209191-19-060615
CIK 0001178253other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 3:10 PM ET
Size
7.3 KB
Accession
0001209191-19-060615
Insider Transaction Report
Form 4
SCYNEXIS INCSCYX
Taglietti Marco
Director
Transactions
- Purchase
Common Stock Warrant (right to buy)
2019-12-12+166,667→ 166,667 totalExercise: $1.10From: 2019-12-12→ Common Stock (166,667 underlying) - Purchase
Common Stock
2019-12-12$0.90/sh+166,667$150,000→ 693,682 total
Footnotes (2)
- [F1]Reflects the purchase on December 12, 2019, of 166,667 shares of the issuer's common stock at a public offering price of $0.90 per share of common stock and accompanying warrant.
- [F2]The warrant expires on the earlier of (i) such date that is six months after the issuer publicly announces the approval from the U.S. Food and Drug Administration for ibrexafungerp for the treatment of vulvovaginal candidiasis and (ii) June 12, 2023.
Documents
Issuer
SCYNEXIS INC
CIK 0001178253
Entity typeother
Related Parties
1- filerCIK 0001408870
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 3:10 PM ET
- Size
- 7.3 KB